Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Qiagen N.V. (NY: QGEN ) 40.95 -0.84 (-2.00%) Streaming Delayed Price Updated: 11:53 AM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Qiagen N.V. < Previous 1 2 3 Next > Strategic Buy Lights Up This Biotech Stock: Time to Invest? July 16, 2024 Life sciences company Illumina Inc. (NASDAQ: ILMN) stock surged over 10% following its announcement of the acquisition of Fluent Biosciences. Via MarketBeat QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications May 30, 2024 From Myriad Genetics, Inc. Via GlobeNewswire QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancer October 26, 2023 From Myriad Genetics, Inc. Via GlobeNewswire Bio-Rad and QIAGEN Announce Patent Settlement and Cross-Licensing Agreement July 26, 2023 From Bio-Rad Laboratories, Inc. Via Business Wire QIAGEN Announces Form 20-F Annual Report Filing for 2022 Results March 13, 2023 From QIAGEN N.V. Via Business Wire QIAGEN and Servier Partner to Develop Companion Diagnostic for Acute Myeloid Leukemia (AML) Therapy Drug March 09, 2023 From QIAGEN N.V. Via Business Wire QIAGEN and SOPHiA GENETICS Forge Partnership to Combine Strengths in Next-Generation Sequencing March 01, 2023 From QIAGEN N.V. Via Business Wire QIAGEN’s tuberculosis blood test QuantiFERON-TB Gold Plus gains CE-marking under new EU IVDR framework February 14, 2023 From QIAGEN N.V. Via Business Wire QIAGEN Exceeds Outlook for Fourth Quarter and Full-Year 2022 With 14% CER Sales Growth in FY 2022 From Non-COVID Product Groups February 07, 2023 From QIAGEN N.V. Via Business Wire QIAGEN Launches EZ2 Connect MDx Platform for Automated Sample Processing in Diagnostic Labs January 17, 2023 From QIAGEN N.V. Via Business Wire QIAGEN N.V. to Release Results for Q4 and Full-Year Results 2022 and Hold Webcast January 17, 2023 From QIAGEN N.V. Via Business Wire QIAGEN Completes Acquisition of Verogen, Strengthening Leadership in Human ID / Forensics With NGS Technologies January 09, 2023 From QIAGEN Via Business Wire QIAGEN and Helix Launch Exclusive Partnership to Advance Next-Generation Sequencing Companion Diagnostics in Hereditary Diseases January 05, 2023 From QIAGEN N.V. Via Business Wire QIAGEN receives FDA approval for companion diagnostic to Mirati Therapeutics’ KRAZATI in non-small cell lung cancer December 13, 2022 From QIAGEN N.V. Via Business Wire QIAGEN launches monkeypox test for NeuMoDx platform to fight global outbreak by boosting research and surveillance November 21, 2022 From QIAGEN N.V. Via Business Wire QIAGEN Exceeds Outlook for Q3 2022 with 18% CER Sales Growth in Non-COVID Product Portfolio and Raises Full-Year 2022 Outlook November 07, 2022 From QIAGEN N.V. Via Business Wire QIAGEN N.V. to Release Results for Q3 2022 and Hold Webcast October 21, 2022 From QIAGEN N.V. Via Business Wire IGI Inex Holding (UK) Becomes Strategic Investor in Quantumrock, Cementing Partnership Between Leading Global Investment Group and AI Asset Tech Frontrunners September 16, 2022 Via ACCESSWIRE QIAGEN Adds New Assays With CE-IVD Certification for NeuMoDx Integrated PCR System September 15, 2022 From QIAGEN N.V. Via Business Wire QIAGEN and Neuron23 Partner to Develop Next-Generation Sequencing Companion Diagnostic for Novel Parkinson’s Disease Drug September 14, 2022 From QIAGEN N.V. Via Business Wire QIAGEN Issues 2021 Sustainability Report August 18, 2022 From QIAGEN N.V. Via Business Wire QIAGEN Launches Syndromic Test for QIAstat-Dx Device to Combat Global Monkeypox Health Emergency August 15, 2022 From QIAGEN N.V. Via Business Wire QIAGEN adds new biopharma products to QIAcuity digital PCR portfolio and launches Expert Custom Assay Design Service July 27, 2022 From QIAGEN N.V. Via Business Wire QIAGEN beats outlook for Q2 2022 and raises full-year 2022 outlook July 26, 2022 From QIAGEN N.V. Via Business Wire QIAGEN’s Clinical Decision Support Platform QCI Surpasses Three Million NGS Patient Test Cases July 19, 2022 From QIAGEN N.V. Via Business Wire QIAGEN N.V. to Release Results for Q2 2022 and Hold Webcast July 07, 2022 From QIAGEN N.V. Via Business Wire U.S. CDC Endorses the Use of Digital PCR Technology for Wastewater Surveillance of Infectious Diseases – Including COVID-19 Outbreaks June 01, 2022 From QIAGEN N.V. Via Business Wire QIAGEN’s Eco-Friendlier Products Earn Prestigious ACT Label May 19, 2022 From QIAGEN N.V. Via Business Wire QIAGEN Expands Syndromic Testing Portfolio with the Launch of Higher-Capacity QIAstat-Dx Rise and Enhanced Panels May 16, 2022 From QIAGEN N.V. Via Business Wire QIAGEN Acquires Majority Stake in Enzymes Provider BLIRT S.A. May 11, 2022 From QIAGEN N.V. Via Business Wire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
